Work with NATx

Whether you're a researcher interested in collaborating or a patient or family member exploring potential nucleic acid–based therapies for a genetic condition, we encourage you to connect with us so we can learn more about your goals.

The NATx Core supports gene-targeted therapies for rare diseases, pediatric conditions, and other areas where traditional drug development falls short, through the following services and expertise:

  • Design and refinement of therapeutic approaches, including antisense oligonucleotides and related nucleic acid modalities
  • Custom oligonucleotide synthesis and modifications for therapeutic discovery and mechanistic studies
  • Integrated design-to-validation workflows that guide projects from sequence design through synthesis and functional evaluation
  • Expert consultation and strategic guidance on advancing nucleic acid therapeutics from discovery-stage research toward translational and clinical development
Submit an order

New to NATx? Tell us about your project

Please complete a brief questionnaire to tell us a little about your project. From there, our team will advise you if we need additional information or if you can submit an order directly. 

If you would like a consultation with the NATx team prior to submitting your first order, please indicate so in your submission. 

Complete the New User form

Unsure where to start?

If you're not sure which service(s) you need at this time, use this contact form to connect with us for more information:

Connect with us

Acknowledgement Statement

Below is suggested language for recognizing the center's contributions to your work: 

Research reported in this publication was supported by the University of Michigan Nucleic Acid Therapeutics (NATx) Core. The NATx Core is grateful for support from the U-M Life Sciences Institute and the U-M Biosciences Initiative. RRID:SCR_027422